Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

I Lancranjan

Showing results (61-70 of 71) with videos related to

Pageof 8
Sort By:
The Journal of Clinical Endocrinology and Metabolism|July 1, 1992
Treatment of macroprolactinomas with the long-acting and repeatable form of bromocriptine: a report on 29 casesA Beckers, P Petrossians, R Abs, et al.
British Journal of Obstetrics and Gynaecology|June 1, 1990
Lactation inhibition by a single injection of a new depot-bromocriptineJ A Kremer, R Rolland, P F van der Heijden, et al.
Hormone Research|January 1, 1991
Comparison between a slow-release oral preparation of bromocriptine and regular bromocriptine in patients with hyperprolactinemia: a double blind, double dummy studyM Moro, C Maraschini, P Toja, et al.
Clinical Endocrinology|March 1, 1994
Cholelithiasis and acromegaly: therapeutic strategiesM Montini, D Gianola, M D Pagani, et al.
The Journal of Clinical Endocrinology and Metabolism|January 1, 1979
A pregnancy in an acromegalic woman during bromocriptine treatment: effects on growth hormone and prolactin in the maternal, fetal, and amniotic compartmentsM Bigazzi, R Ronga, I Lancranjan, et al.
The Journal of Clinical Endocrinology and Metabolism|September 22, 2000
Cardiovascular effects of depot long-acting somatostatin analog Sandostatin LAR in acromegalyA Colao, P Marzullo, D Ferone, et al.
Clinical Endocrinology|April 1, 1992
Efficacy of a new long-acting injectable form of bromocriptine in hyperprolactinaemic patientsM D Pagani, F Tengattini, M Montini, et al.
Acta Endocrinologica|November 1, 1991
Chronic treatment with parlodel LAR of patients with prolactin-secreting tumours. Different responsiveness of micro- and macroprolactinomasC Maraschini, M Moro, A Masala, et al.
Gynecological Endocrinology : the Official Journal of the International Society of Gynecological Endocrinology|September 1, 1991
A new oral slow release form of bromocriptine, Parlodel SRO, in the chronic treatment of 26 hyperprolactinemic patientsD Gianola, A Pedroncelli, M Montini, et al.
Metabolism: Clinical and Experimental|August 1, 1996
Sandostatin LAR: a promising therapeutic tool in the management of acromegalic patientsI Lancranjan, C Bruns, P Grass, et al.
Pageof 8

Showing results (61-70 of 71) with videos related to

Sort By:
Pageof 8
The Journal of Clinical Endocrinology and Metabolism|July 1, 1992
Treatment of macroprolactinomas with the long-acting and repeatable form of bromocriptine: a report on 29 casesA Beckers, P Petrossians, R Abs, et al.
British Journal of Obstetrics and Gynaecology|June 1, 1990
Lactation inhibition by a single injection of a new depot-bromocriptineJ A Kremer, R Rolland, P F van der Heijden, et al.
Hormone Research|January 1, 1991
Comparison between a slow-release oral preparation of bromocriptine and regular bromocriptine in patients with hyperprolactinemia: a double blind, double dummy studyM Moro, C Maraschini, P Toja, et al.
Clinical Endocrinology|March 1, 1994
Cholelithiasis and acromegaly: therapeutic strategiesM Montini, D Gianola, M D Pagani, et al.
The Journal of Clinical Endocrinology and Metabolism|January 1, 1979
A pregnancy in an acromegalic woman during bromocriptine treatment: effects on growth hormone and prolactin in the maternal, fetal, and amniotic compartmentsM Bigazzi, R Ronga, I Lancranjan, et al.
The Journal of Clinical Endocrinology and Metabolism|September 22, 2000
Cardiovascular effects of depot long-acting somatostatin analog Sandostatin LAR in acromegalyA Colao, P Marzullo, D Ferone, et al.
Clinical Endocrinology|April 1, 1992
Efficacy of a new long-acting injectable form of bromocriptine in hyperprolactinaemic patientsM D Pagani, F Tengattini, M Montini, et al.
Acta Endocrinologica|November 1, 1991
Chronic treatment with parlodel LAR of patients with prolactin-secreting tumours. Different responsiveness of micro- and macroprolactinomasC Maraschini, M Moro, A Masala, et al.
Gynecological Endocrinology : the Official Journal of the International Society of Gynecological Endocrinology|September 1, 1991
A new oral slow release form of bromocriptine, Parlodel SRO, in the chronic treatment of 26 hyperprolactinemic patientsD Gianola, A Pedroncelli, M Montini, et al.
Metabolism: Clinical and Experimental|August 1, 1996
Sandostatin LAR: a promising therapeutic tool in the management of acromegalic patientsI Lancranjan, C Bruns, P Grass, et al.
Pageof 8